Clinical trial
Intravitreal Bevacizumab in Agioid Streaks
NCT00406250 · University of Campania Luigi Vanvitelli, Other · Completed
Key facts
| NCT number | NCT00406250 |
|---|---|
| Title | Intravitreal Bevacizumab in Agioid Streaks |
| Official title | Intravitreal Bevacizumab for Choroidal Neovascularization Secondary to Angioid Streaks: 24 Months Follow-up |
| Lead sponsor | University of Campania Luigi Vanvitelli, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Angioid Streaks, Choroidal Neovascularization |
| Intervention type | Drug |
| Interventions | intravitreal injection |
| Enrollment | 5 |
| Start date | Nov 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | May 1, 2009 |
| First posted | Dec 4, 2006 |
| Last update posted | Feb 8, 2016 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: